ACUTE MYELOBLASTIC LEUKEMIA IN CHILDREN, TREATMENT AND PROGNOSIS 125
نویسندگان
چکیده
منابع مشابه
Prognosis of acute myeloblastic leukemia: chromosomal correlation.
A correlation was made between chromosomal findings in the marrow of AML patients obtained during the course of the disease, some of the clinical and cytologic features, and the survival span of these patients. The median survival time for each patient was obtained by the use of log-probability paper. Of the 69 patients with AML studied, 29 showed abnormal metaphases in the marrow at least once...
متن کاملTreatment of adult acute myeloblastic leukemia.
The introduction of combination chemotherapy in the treatment of adult acute leukemia has had a profound impact on the response and duration of survival of patients with adult acute myeloblastic leukemia. In the past decade, the combination of cytosine arabinoside with an anthracycline antibiotic, either daunorubicin, adriamycin, or rubidazone, has been responsible to a large degree for the suc...
متن کاملActual biological diagnosis of acute myeloblastic leukemia in children
Acute myeloblastic leukemia accounts for approximately 20% of acute leukemias in children. The days the microscope represented the main tool in the diagnosis and classification of Acute Myeloblastic Leukemia seem to be very far. This review summarizes the current diagnosis of this malignancy, where the morphological, cytochemical, immunophenotyping, cytogenetic and molecular characterization re...
متن کاملFACTORS EFFECTIVE IN THE PROGNOSIS OF NEUTROPENIC FEVER IN THE CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Background & Aims: Febrile Neutropenia (FN) is one of the common complications of chemotherapy in the children with malignancy. In this study, we investigated the effective factors in response to the treatment of patients with febrile neutropenia. By using these factors, it is possible to have a better analysis about the severity of infection of these patients and it will helpful in choosing th...
متن کاملAcute Myeloblastic Leukemia in Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hematopoietic stem cell disorder in which the blood cells demonstrate aberrant interactions with serum complement. In part, this is due to the absence of the complement regulatory protein, decay accelerating factor (DAF). A small number of patients with PNH have gone on to develop acute nonlymphocytic leukemia, which is thought to arise f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Research
سال: 1997
ISSN: 0031-3998,1530-0447
DOI: 10.1203/00006450-199705000-00144